Mucoadhesive and thermogelling systems for vaginal drug delivery

Adv Drug Deliv Rev. 2015 Sep 15:92:39-52. doi: 10.1016/j.addr.2015.02.001. Epub 2015 Feb 13.

Abstract

This review focuses on two formulation approaches, mucoadhesion and thermogelling, intended for prolonging residence time on vaginal mucosa of medical devices or drug delivery systems, thus improving their efficacy. The review, after a brief description of the vaginal environment and, in particular, of the vaginal secretions that strongly affect in vivo performance of vaginal formulations, deals with the above delivery systems. As for mucoadhesive systems, conventional formulations (gels, tablets, suppositories and emulsions) and novel drug delivery systems (micro-, nano-particles) intended for vaginal administration to achieve either local or systemic effect are reviewed. As for thermogelling systems, poly(ethylene oxide-propylene oxide-ethylene oxide) copolymer-based and chitosan-based formulations are discussed as thermogelling systems. The methods employed for functional characterization of both mucoadhesive and thermogelling drug delivery systems are also briefly described.

Keywords: In situ gel forming systems; Methods for mucoadhesion testing; Methods for thermogelling testing; Mucoadhesive formulations; Vaginal mucosa; Vaginal secretions.

Publication types

  • Review

MeSH terms

  • Administration, Intravaginal
  • Chitosan / chemistry
  • Drug Delivery Systems / methods*
  • Drug Evaluation, Preclinical
  • Female
  • Humans
  • Models, Biological
  • Nanoparticles
  • Poloxamer / chemistry
  • Suppositories / administration & dosage
  • Suppositories / pharmacokinetics
  • Technology, Pharmaceutical
  • Vagina / physiology
  • Vaginal Absorption
  • Vaginal Creams, Foams, and Jellies / administration & dosage*
  • Vaginal Creams, Foams, and Jellies / pharmacokinetics*

Substances

  • Suppositories
  • Vaginal Creams, Foams, and Jellies
  • Poloxamer
  • Chitosan